CTS Stock Analysis: CTS | NYSE
Electronic Components | NYSE, USA | Market Cap: 1.715m USD | 12M Return: 46% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.9M
EPS Trend: 1.7%
Qual. Beats: 1
Rev. Trend: -38.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CTS Corporation (NYSE: CTS) is a U.S.-based electronic components manufacturer specializing in sensors, connectivity components, and actuators for transportation, industrial, medical, aerospace, and defense end markets. The company operates across North America, Europe, and Asia and is classified within the Information Technology sector under the Electronic Manufacturing Services sub-industry, a segment that includes firms supplying components and assemblies to original equipment manufacturers across multiple industries. Diversified exposure across heavy-industrial and regulated end markets is a common structural feature of the sector.
CTSs product portfolio includes controls, pedals, sensors, switches, transducers, piezo sensing products, EMI/RFI filters, capacitors, resistors, RF filters, frequency control products, and piezo microactuators and rotary actuators. These items span active and passive electronic components, which together form the foundational building blocks of electronic assemblies. The company reaches customers through internal sales engineers, independent manufacturer representatives, and third-party distributors, a hybrid channel structure typical of mid-sized component suppliers. Founded in 1896 and headquartered in Lisle, Illinois, CTS has been listed on the NYSE since 1987.
- EV adoption drives automotive sensor and pedal demand
- Aerospace and defense bookings expand at higher margins
- M&A strategy broadens sensing and connectivity portfolio
| Net Income: 69.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.16 > 1.0 |
| NWC/Revenue: 28.89% < 20% (prev 29.31%; Δ -0.41% < -1%) |
| CFO/TA 0.13 > 3% & CFO 103.9m > Net Income 69.1m |
| Net Debt (36.6m) to EBITDA (129.0m): 0.28 < 3 |
| Current Ratio: 2.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (29.0m) vs 12m ago -4.37% < -2% |
| Gross Margin: 38.71% > 18% (prev 37.00%; Δ 1.71% > 0.5%) |
| Asset Turnover: 72.06% > 50% (prev 67.36%; Δ 4.71% > 0%) |
| Interest Coverage Ratio: 19.38 > 6 (EBIT TTM 94.2m / Interest Expense TTM 4.86m) |
| A: 0.21 (Total Current Assets 266.0m - Total Current Liabilities 105.4m) / Total Assets 777.2m |
| B: 0.94 (Retained Earnings 729.5m / Total Assets 777.2m) |
| C: 0.12 (EBIT TTM 94.2m / Avg Total Assets 771.3m) |
| D: 2.54 (Book Value of Equity 557.5m / Total Liabilities 219.7m) |
| Altman-Z'' = 7.90 = AAA |
| DSRI: 1.08 (Receivables 99.2m/85.1m, Revenue 555.9m/515.6m) |
| GMI: 0.96 (GM 37.00% / 38.71%) |
| AQI: 0.95 (AQ_t 0.50 / AQ_t-1 0.53) |
| SGI: 1.08 (Revenue 555.9m / 515.6m) |
| TATA: -0.04 (NI 69.1m - CFO 103.9m) / TA 777.2m) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of July 28, 2026, the stock is trading at USD 60.41 with a total of 171,929 shares traded. Over the past week, the price has changed by +2.04%, over one month by -6.44%, over three months by +7.98% and over the past year by +45.95%.
Current recommended Stop Loss: 55.60 (which is 8% or 2.2 ATR below the current price).
CTS has no consensus analysts rating.
| Analysts Target Price | 58 | -4% |
P/E Trailing = 25.6368
P/E Forward = 24.6914
P/S = 3.0918
P/B = 3.0769
P/EG = 1.543
Revenue TTM = 555.9m USD
EBIT TTM = 94.2m USD
EBITDA TTM = 129.0m USD
Long Term Debt = 62.5m USD (from longTermDebt, last quarter)
Short Term Debt = 4.10m USD (from shortTermDebt, last quarter)
Debt = 127.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 32.5m
Net Debt = 36.6m USD (calculated: Debt 127.4m - CCE 90.9m)
Enterprise Value = 1.75b USD (1.72b + Debt 127.4m - CCE 90.9m)
Interest Coverage Ratio = 19.38 (Ebit TTM 94.2m / Interest Expense TTM 4.86m)
EV/FCF = 19.99x (Enterprise Value 1.75b / FCF TTM 87.6m)
FCF Yield = 5.00% (FCF TTM 87.6m / Enterprise Value 1.75b)
FCF Margin = 15.76% (FCF TTM 87.6m / Revenue TTM 555.9m)
Net Margin = 12.44% (Net Income TTM 69.1m / Revenue TTM 555.9m)
Gross Margin = 38.71% ((Revenue TTM 555.9m - Cost of Revenue TTM 340.7m) / Revenue TTM)
Gross Margin QoQ = 38.45% (prev 38.73%)
Tobins Q-Ratio = 2.25 (Enterprise Value 1.75b / Total Assets 777.2m)
Interest Expense / Debt = 3.81% (Interest Expense 4.86m / Debt 127.4m)
Taxrate = 22.59% (20.2m / 89.3m)
NOPAT = 72.9m (EBIT 94.2m * (1 - 22.59%))
Current Ratio = 2.52 (Total Current Assets 266.0m / Total Current Liabilities 105.4m)
Debt / Equity = 0.23 (Debt 127.4m / totalStockholderEquity, last quarter 557.5m)
Debt / EBITDA = 0.28 (Net Debt 36.6m / EBITDA 129.0m)
Debt / FCF = 0.42 (Net Debt 36.6m / FCF TTM 87.6m)
Total Stockholder Equity = 551.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.96% (Net Income 69.1m / Total Assets 777.2m)
RoE = 12.53% (Net Income TTM 69.1m / Total Stockholder Equity 551.8m)
RoCE = 15.33% (EBIT 94.2m / Capital Employed (Equity 551.8m + L.T.Debt 62.5m))
RoIC = 11.25% (NOPAT 72.9m / Invested Capital 648.1m)
WACC = 9.75% (E(1.72b)/V(1.84b) * Re(10.25%) + D(127.4m)/V(1.84b) * Rd(3.81%) * (1-Tc(0.23)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.42 | Cagr: -3.25%
[DCF] Terminal Value 73.26% ; FCFF base≈83.5m ; Y1≈94.3m ; Y5≈133.3m
[DCF] Fair Price = 55.28 (EV 1.62b - Net Debt 36.6m = Equity 1.58b / Shares 28.6m; r=9.75% [WACC]; 5y FCF grow 13.17% → 2.50% )
EPS Correlation: 1.69 | EPS CAGR: 0.10% | SUE: 2.30 | # QB: 1
Revenue Correlation: -38.01 | Revenue CAGR: -1.82% | SUE: 0.67 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.61 | Chg30d=+0.00% | Revisions=+25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.65 | Chg30d=+0.00% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.43 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+9.0% | GrowthRev=+5.5%
EPS next Year (2027-12-31): EPS=2.89 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+18.9% | GrowthRev=+6.0%